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Blood vessels are made up of several distinct cell types. Although it was originally 
thought that the tunica media of blood vessels was composed of a homogeneous 
population of fully differentiated smooth muscle cells, more recent data suggest the 
existence of multiple smooth muscle cell subpopulations in the vascular wall. One of the 
cell types contributing to this heterogeneity is the novel, irregularly shaped, 
noncontractile cell with thin processes, termed interstitial cell, found in the tunica media 
of both veins and arteries. While the principal role of interstitial cells in veins seems to 
be pacemaking, the role of arterial interstitial cells is less clear. This review summarises 
the knowledge of the functional and structural properties of vascular interstitial cells 
accumulated so far, offers hypotheses on their physiological role, and proposes 
directions for future research. 
KEYWORDS: interstitial cell, vascular smooth muscle cell, phenotype, intracellular calcium, 
filopodia, confocal imaging, immunocytochemistry, patch clamp 
 
INTRODUCTION 
Blood vessels are made up of several distinct cell types, such as endothelial cells, pericytes, smooth 
muscle cells, neurones (endings), fibroblasts, and various inflammatory cells, which all work in concert to 
ensure an optimal supply of nutrients and oxygen to tissues. Until approximately the early 1990s, the 
prevailing view was that the muscular layer, tunica media, consisted of a homogeneous population of 
mature, differentiated, contractile, vascular smooth muscle cells (VSMCs). This was despite the 
occasional paper which demonstrated the presence of cells with processes in various tissues, including 
blood vessels[1,2]. At that time, the cells with processes were thought to be of neuronal nature, so they 
received little attention. A number of works starting from the 1990s demonstrated the presence of distinct 
VSMC subpopulations in normal blood vessels[3,4,5,6,7]. Progress in cell isolation and microscopy 
techniques over the last several decades has made it possible to observe live single cells in unprecedented 
detail. In the VSMC field in the early 2000s, this ability has allowed, among other discoveries, the 
(re)discovery of rare, irregularly shaped, noncontractile cells with thin processes, accompanying VSMCs 
and their functional and structural investigation on a single cell level.  
The presence of cells which fall in the category of irregularly shaped with processes have so far been 
confirmed in every tissue which contains smooth muscle cells, apart from airway smooth muscle 
(oesophagus[8,9], stomach[10,11], small intestine[12,13], colon[14,15], ureter[16,17], urinary 
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bladder[18,19,20,21,22], urethra[23,24,25,26,27], arteries[28,29,30,31], veins[32,33,34,35], lymphatic 
vessels[36], uterus[37,38], Fallopian tubes[39], prostate[40,41], and vas deferens[42]). Cells of similar 
morphology have also been described in the heart muscle[43], close to cardiomyocytes, in both 
atria[44,45] and ventricles[46], suggesting their presence throughout the cardiovascular system. Earlier 
hypotheses that irregularly shaped cells with processes accompany smooth muscle cells throughout the 
body may need extending, as these cells were also reported in locations unrelated to and/or at some 
distance from muscle[47,48,49,50]. 
As is usually the case in new and developing areas, there is a considerable dissonance in the 
nomenclature of these cells (to which the author contributed with a fair share). This multitude of terms 
will yet have to result in a scientific community–wide agreement on the name and (preliminary) 
classification of all the “strange” cells with processes in blood vessels and other tissues (apart from the 
well-established interstitial cells of Cajal [ICCs] in the gastrointestinal tract). These cells have so far been 
referred to as ICCs[18,31,32,33,34,35,48,51], ICC-like cells[28,52], immature VSMCs[29], interstitial 
cells[30,53,54,55], pacemaker cells[23,56], interstitial Cajal-like cells[16,39,44,46,47,49,50,57] or, most 
recently, telocytes[58,59]. From the research so far, it is already clear that, rather than a uniform group, 
these cells are a conglomerate of subpopulations, each with its slightly different structure and function, 
depending on their localisation in the body. In some instances, the naming of these cells as ICCs seems 
premature, as not enough data have been collected about them to satisfy the ultrastructural[60,61] or 
functional criteria for an ICC. Until we gain a better understanding of their origin and of the differences 
between their subpopulations, a single name for them would help to avoid much of the confusion in 
future. Similar to Harhun et al.[54], these cells will be referred to in this text as interstitial cells (ICs), 
which is a compromise between inclusiveness of all subpopulations and accuracy in naming the 
phenomenon. 
This review will be restricted to vascular ICs. Gastrointestinal tract ICs, known as ICCs, have been 
the subject of extensive investigation over a number of years, which resulted in a wealth of data and a 
number of review papers (e.g., [62,63,64,65]). Likewise, there have been several review papers published 
recently on urinary tract ICs[16,66,67,68,69]. As for the ICs in other locations, their investigation is at the 
very early stage and data, especially on their function, are scarce and require further studies. This review 
builds on two earlier reviews[53,54], summarises the knowledge of the structure and functional properties 
of vascular ICs accumulated since their rediscovery 7 years ago, offers hypotheses on their physiological 
role, and proposes directions for future research and potential utilisation. 
MORPHOLOGY 
ICs in blood vessels are irregularly shaped with long thin processes, filopodia, which are their most 
prominent feature (Fig. 1). The thickness of filopodia ranges from a fraction to a couple of micrometers, 
and their length can be up to a couple of hundred micrometers[35]. In the majority of cases, the filopodia 
do not have varicosities (moniliform filopodia were described only for ICs of rat mesentery[50]) and are 
sometimes seen branching (up to 5
th
 order[35]). Confocal imaging of calcium in cells loaded with a 
calcium-sensitive fluorescent indicator[32], and electron microscopy of ICs either in single cell 
suspension or in intact tissue[28], have confirmed that the filopodia are continuous with the cell body. 
The function of filopodia was investigated in more detail in ICs of guinea pig small mesenteric 
arteries. It was found that in single isolated ICs, they were growing in length (max. speed at 20–22°C of 
~800 nm/min[28]) in the absence of serum or nutrients other than glucose. The elongation of filopodia 
seemed random in direction. They were observed growing sometimes toward the neighbouring VSMCs 
and sometimes past them. The ability of latrunculin B, an actin polymerisation inhibitor, to abolish the 
growth of filopodia suggested that their elongation is based on actin polymerisation[28]. It is still not 
clear what role the elongation of filopodia plays in ICs and whether it occurs in the intact tissue as well. It 
has not been reported for ICs in any other tissues. So far, it is still only a hypothesis that the elongation of 
filopodia is a reaction of ICs to the loss of contact with the extracellular matrix (ECM) and the adjoining  




FIGURE 1. Scanning electron micrograph of a single IC isolated 
from guinea pig small mesenteric arteries. Scale bar: 5 μm. 
cells, resulting from enzymatic dispersal of the tissue. Indeed, the transmission electron micrographs of 
artery segments did not show cells with excessive numbers of filopodia in the intact tissue, nor did these 
filopodia appear longer than the filopodia of isolated ICs[28,29,30] (although it can be argued that this 
observation is due to thinness of slices used in electron microscopy (~90 nm), which results in seeing only 
few filopodia in their incomplete length). Interestingly, when the cell isolation was performed in a culture 
medium (which has an abundance of nutrients), the resulting single ICs had fewer and shorter filopodia 
than the ones isolated in physiological solution containing only glucose as a nutrient[29]. This implies 
that nutrient deprivation (which would be the case if ICs were out of their natural environment) might 
stimulate the development of filopodia in ICs. A similar principle was found to operate in Rhodnius bugs, 
whose epidermal cells developed filopodia in response to oxygen deprivation[70]. Thus, the elongation of 
filopodia could be seen as a cell’s effort to re-establish its connections. This logically leads to the question 
of whether the ICs in blood vessels are not merely an artefact of the cell isolation procedure – a result of 
the phenotypic modulation of VSMCs triggered by the disruption of tissue integrity during the isolation 
procedure and manifested, among other phenomena, by the development of filopodia (see below, in 
“Genuine cell type or artefact?”). 
The bodies of ICs are elongated and irregular (in contrast to spindle-shaped VSMCs). Only two 
exceptions have been observed so far: the stellate-shaped cells with filopodia described in the 
subendothelial intramuscular layer of rabbit portal vein[32] and at the external side of media in the human 
pulmonary vein[71]. Nothing is known about the function of this subpopulation of ICs, as their low 
abundance (in the case of rabbit portal vein) precluded more detailed investigation. 
Approximately a third of arterial ICs which underwent time-lapse imaging during the investigation of 
their filopodia have shown an active change of their body shape[28]. This manifested as a generation or 
withdrawal of cytoplasmic protrusions at various positions on the cell body, giving it an irregular shape 
(Fig. 2). Similar to filopodial elongation, this process was also actin polymerisation–dependent and was 
taking place in a nutrient-poor environment with only glucose as a source of energy. In conjunction with  




FIGURE 2. A series of transmitted light images of an arterial IC undergoing shape 
change. The cell was adhering to a laminin-coated coverslip and was placed in a 
physiological salt solution. Several different phenomena can be observed: elongation 
(green arrows), thinning (yellow arrows) or thickening of filopodia (red arrows), 
development of protuberations (blue arrows), and fusion of a protuberation with the 
thickened filopodium (purple arrow). 
the fact that actin of vascular ICs (see below, in “Ultrastructure”) is organised into stress fibres, this 
information suggested that they might be able to migrate, which gave rise to speculations that they 
participate in remodelling of the vascular wall. Such speculations are reinforced by the elongated shape of 
ICs, their localisation in situ among VSMCs, and the finding that morphologically similar cells, 
gastrointestinal ICCs, after having their c-kit receptors blocked with antibodies, dedifferentiate into a 
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smooth muscle cell–like phenotype[72], all suggesting a close developmental relation between ICs and 
smooth muscle cells. However, there is currently no experimental evidence which would shed more light 
into the role of ICs in vascular remodelling. 
GENUINE CELL TYPE OR ARTEFACT? 
The VSMC is regarded as a multifunctional mesenchymal cell[73] of substantial plasticity, capable of 
modulating its phenotype in response to changes in its microenvironment. It is therefore conceivable that 
severing its connections to the ECM and to adjoining VSMCs during a tissue-dispersal procedure could 
act as a trigger for the modulation of its phenotype. It was observed that upon placement of single isolated 
VSMCs in cell culture, they spontaneously and reversibly modulate their phenotype from “contractile” to 
“synthetic” within 3–7 days[74,75].  
VSMCs are surrounded by basal lamina whose principal protein components are collagen IV and 
laminin. These proteins, bound to cells via integrins, transmembrane proteins capable of both inside-out 
and outside-in signalling[76], are known to promote the contractile VSMC phenotype[77,78]. It is the 
signals received through these contacts which appear to play a major role in maintaining mature 
contractile VSMCs in their current phenotype and preventing them from spontaneous phenotypic 
modulation into the synthetic phenotype, seen in cell cultures. Enzymes used for tissue dispersal, such as 
collagenase, elastase, or papain, cleave ECM proteins and could therefore damage or completely remove 
the basal lamina and expose the VSMCs to contacts with ECM proteins, such as collagen I or fibronectin 
(or their fragments), which promote VSMC conversion to a synthetic phenotype[77,79,80,81].  
Significant efforts in the vascular IC research field were directed toward answering the question of 
whether they are genuine or their occurrence is triggered by tissue dispersion. There are several lines of 
indirect evidence which, observed as a whole, strongly suggest that ICs do reside constitutively in the 
vascular wall.  
The strongest evidence is provided by the transmission electron micrographs of sections taken from 
intact vascular segments. These show cells with processes of similar thickness to those observed in single 
cell suspensions, located among VSMCs in the tunica media[28,29,30,31]. Using potassium 
permanganate as one of the staining steps resulted in differential staining of ICs (darker) compared to 
VSMCs[30].  
Secondly, mature VSMCs would require a period of time to develop some of the ultrastructural 
features of ICs. The fact that ICs were found in single cell suspensions immediately after dissociation[28] 
makes it highly unlikely that mature VSMCs could, in such a short time, develop filopodia several tens of 
micrometers long, rearrange their actin cytoskeleton into stress fibres laying in various directions[28], or 
down-regulate smoothelin, a cytoskeleton-associated protein found only in contractile smooth muscle 
cells[82,83,84], which was all but absent in ICs of guinea pig small mesenteric arteries[29] (smoothelin 
has been reported to remain present in cells up to 5 days after the removal of tissue[82]).  
Thirdly, if a supramaximal concentration of the actin polymerisation inhibitor latrunculin B is present 
continuously in the tissue from the moment of excision until its dissociation, it should block the 
development of any filopodia. If ICs were indeed an artefact of cell isolation, then only VSMCs would be 
seen in the resulting suspension. The fact that ICs were found in suspension despite this intervention[29] 
suggests that they must have existed in the tissue before the commencement of dispersion. 
Fourthly, if the basal lamina was substantially corrupted or destroyed, the immunolabelling of its 
protein constituents in conjunction with confocal imaging would detect the damage. This was not the case 
– the cell surface coverage by laminin or collagen IV between the two cell types did not show substantial 
differences and the signal intensity in ICs was not lower either[29]. The experiments proved that ICs 
possessed basal lamina, which ruled out the possibility that they were myofibroblasts[85].  




The ultrastructure of vascular ICs has not been investigated to such an extent as that of ICs in other 
tissues or of ICCs in the gastrointestinal tract, for which the ultrastructural criteria have been well 
established[60].  
One of the first ultrastructural differences between vascular ICs and VSMCs was revealed not by 
electron, but by confocal microscopy. The actin staining patterns in ICs from guinea pig small mesenteric 
arteries produced by a fluorescent derivative of phalloidin have shown that actin was organised into stress 
fibres running in various directions in the cell. This is different to its arrangement in VSMCs, where it 
appeared tightly packed and no stress fibres could be seen[28], and probably reflects different functions of 
actin filaments in these two cell types. Two other cytoskeletal components, α-actinin and vinculin, also 
differed in their subcellular distribution, supporting observations on actin. Both of these proteins were 
distributed throughout the cytoplasm in arterial ICs, whereas in VSMCs, they were restricted to a thin 
subplasmalemmal layer[30]. While VSMCs require relatively fast sliding of actin and myosin filaments 
during contraction, the noncontractile (but not immobile) ICs could use actin stress fibres for the much 
slower type of movement during shape change and, presumably, migration.  
Investigations using transmission electron microscopy did not reveal any dramatic ultrastructural 
differences between vascular ICs and the surrounding VSMCs. They have shown the presence of 
caveolae along the plasmalemma (in ICs of guinea pig small mesenteric arteries[28], human aorta[31], 
and rat cerebral artery[30]), multilobar nucleus[28,30,31], well-developed endoplasmic reticulum[30,31], 
intermediate filaments[31], and numerous mitochondria[30,31], mainly clustered around the nucleus. ICs 
formed cell-to-cell junctions with the adjoining VSMCs[29,30,31], but no gap junctions or specialised 
structures were detected in these zones in human aortic ICs[31]. In the filopodia of arterial ICs, the 
filaments could be sometimes seen embedded within the cytoplasmic matrix and running along the 
longitudinal axis of the filopodium, in parallel to the plasmalemma[28], but no other structures or 
varicosities were found.  
Clearly, our knowledge of vascular IC ultrastructure is only at its beginnings. As the most prominent 
feature of ICs, the filopodia might hold important clues to IC function. For this reason, the investigation 
of their ultrastructure, especially in intact tissue, would be of high interest.  
LOCALISATION 
ICs have so far been reported in rabbit portal vein[32], guinea pig small mesenteric arteries[28], rat 
middle cerebral artery[30], mouse mesenteric artery[86], human aorta and carotid artery[31], human 
pulmonary vein[71], and frog postcaval vein[34], with several other unpublished observations in various 
species and vascular beds. In the mesenteric artery tree, they were found in arteries of every branch 
order[29] (diameter range approximately 110–520 μm[28]). This observation and the presence of ICs in a 
range of vascular beds, and in species ranging from amphibian to several mammalian species, including 
humans, strongly argues in favour of the view that ICs accompany VSMCs throughout the body.  
The information about the localisation of ICs in the vascular wall comes from transmission electron 
microscopy and, in the case of c-kit–positive ICs, from confocal microscopy. The localisation of ICs 
within the vascular wall varies and is dependent on the vascular bed. In rabbit portal vein and guinea pig 
mesenteric arteries, the ICs can be found both in the subendothelial layer and deeper in the 
media[28,29,32,35]; in rat cerebral artery, they are found deep in the media[30]; whereas in human aorta, 
they appear to be present along the media-adventitia border[31]; and in human pulmonary vein, on the 
external side and deep in the media[71]. In frog postcaval vein, a spontaneously active blood vessel, the 
methylene blue staining helped to visualise spindle-shaped elongated cells, occasionally with filopodia, 
located in the medial layer[34].  
Worth noting is an irregular, cluster-like distribution of ICs described in rabbit portal vein[35] and in 
human aorta and pulmonary vein[31,71], which results in some vessel segments having a high density of 
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ICs and some sections having none. This is consistent with the existence of multiple, specialised 
pacemaker regions in the portal vein[87,88].  
The works published so far did not find evidence that vascular ICs formed networks, unlike ICCs in 
the gastrointestinal tract[89]. Given their sparsity in the wall of guinea pig small mesenteric arteries (~5% 
of all cells in single cell suspensions[28]), their interconnection into networks seems unlikely if they are 
evenly distributed, as it would require filopodia hundreds of micrometers long. There are indications that 
rabbit portal vein ICs (which form clusters and are thus positioned closer to each other) are 
interconnected[35]. However, there are no data on the tissue level which would unambiguously support 
this hypothesis. 
MARKERS AND STRUCTURAL PROTEINS 
The phenotype of a cell is defined by the proteins it expresses. Initial indications that ICs might be 
somehow related to smooth muscle cells were, in the case of vascular ICs, followed by investigations of 
proteins which these cells express and genes they transcribe. This was done in order to determine the cell 
lineage the ICs belong to, which could help with the elucidation of their physiological role(s), especially 
in arteries. Initial investigations focused on marker proteins for several cell types and have revealed that 
portal vein ICs were c-kit positive[32] and arterial ICs were not, but expressed smooth muscle 
myosin[28]. As the physiological role of portal vein ICs became clearer in the meantime, arterial ICs 
received more attention. Table 1 summarises the findings of experiments involving the 
immunocytochemical detection of proteins, and Table 2 lists the findings on gene transcription into 
mRNA obtained with quantitative or conventional reverse transcription PCR (RT-PCR). 
TABLE 1 
Expression of Proteins by Vascular ICs and VSMCs 
Protein Name Expression in ICs Expression in VSMCs 
Protein gene product 9.5  – [29] – [29] 
Von Willebrand factor  – [29] – [29] 
C-kit  + [32,86]; – [28,31] – [28,32,86] 
Desmin + [28,30] + [28,30] 
Vimentin + [28] + [28] 
Smooth muscle α-actin  + [29,30]; – [31,71] + [29,30,71] 
Smooth muscle myosin heavy chain  + [28,29,30] + [28,29,30] 
Smoothelin (+)– [29] + [29] 
Myosin light chain kinase  (+)– [29] + [29] 
Calponin – [30] + [30] 
Vinculin + [30] + [30] 
α-Actinin + [30] + [30] 
Fibronectin (on cell surface) – [29] – [29] 
Collagen IV (on cell surface) + [29] + [29] 
Laminin (on cell surface) + [29] + [29] 
Methylene blue staining (whole tissue) + [32]; – [28] – [28,32] 




Transcription of Protein Genes by Vascular ICs and VSMCs 
Gene for: Transcription in ICs Transcription in VSMCs 
Protein gene product 9.5  – [30] – [30] 
C-kit – [30] – [30] 
Vascular endothelial growth factor A  – [30] – [30] 
CD34 – [30] – [30] 
Prolyl-4-hydroxylase  – [30] – [30] 
CD68 – [30] – [30] 
NG2 – [30] – [30] 
Prominin 1 – [30] – [30] 
Mast cell carboxypeptidase A  – [30] – [30] 
Desmin + [114] + [114] 
Vimentin + [114] + [114] 
Smooth muscle α-actin  + [114] + [114] 
Smooth muscle myosin heavy chain  + [30] 
+ (SM1 isoform)[114] 
– (SM2 isoform)[114] 
+ [30] 
+ (SM1 isoform) [114] 
+ (SM2 isoform)[114] 
Myosin light chain kinase  + [114] + [114] 
Calponin + (but ~4 times lower than in 
VSMCs)[30] 
+ [30] 
These results show that vascular ICs are negative for markers of neuronal cells (protein gene product 
9.5[90]), endothelial cells (von Willebrand factor[91], vascular endothelial growth factor A[92], and 
CD34[93]), fibroblasts (CD34 and proline-4-hydroxylase[94]), macrophages (CD68[95]), pericytes 
(NG2[96]), stem cells (prominin 1[97]), or mast cells (mast cell carboxypeptidase A[98]). The expression 
of smooth muscle myosin heavy chain (SM-MHC) by ICs rules out the possibility that they are dendritic 
cells[99]. The absence of fibronectin and the presence of basal lamina proteins collagen IV and laminin 
on the cell surface[29], in conjunction with the expression of intermediate filament desmin in the cell 
cytoplasm[28,30], argue against ICs being myofibroblasts[85]. It is unlikely that ICs are fibroblasts as, 
apart from lacking fibroblast markers, they express smooth muscle α-actin and desmin, which are not 
expressed by fibroblasts[100]. The data in the tables corroborate the hypothesis that ICs belong to the 
VSMC lineage by demonstrating the presence of a number of proteins and smooth muscle markers (or 
their mRNAs) in both cell types (smooth muscle α-actin, SM-MHC, desmin, vimentin, vinculin, α-
actinin)[101,102]. Other smooth muscle markers (smoothelin, myosin light chain kinase [MLCK], and 
calponin) were either absent or expressed significantly less in arterial ICs compared to VSMCs[29,30]. 
Because these markers are expressed by mature, differentiated smooth muscle cells capable of 
contraction, the arterial ICs, falling short of expressing the full protein inventory of VSMCs, appear to be 
their immature or dedifferentiated subpopulation.  
Portal vein ICs were positive for c-kit, a tyrosine kinase receptor for stem cell factor, which is now an 
established marker of ICCs in the gastrointestinal tract[103,104]. C-kit labelling has replaced methylene 
blue staining as the principal method of visualisation of ICs. The presence of c-kit sometimes coincides 
with, but is not a requirement for, ICs’ ability to produce rhythmic depolarisations, as demonstrated by c-
kit–negative urethral ICs[23], and suggested by the ability of murine portal vein to produce rhythmic 
depolarisations and contractions despite having no c-kit–positive cells[105]. The disadvantage of both 
staining approaches is that they do not work in single isolated cells. It is presumed that c-kit is being shed 
and/or down-regulated from the cell membrane upon tissue dispersion. 
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Despite efforts, there is still no known specific marker for arterial ICs. This is perhaps the largest 
obstacle in this research field, as it precludes visualisation of ICs in intact tissues and separation of ICs 
from the bulk of VSMCs in single cell suspensions. 
Vascular ICs did not contract after administration of noradrenaline, caffeine, membrane 
depolarisation by 60 mM K
+
 solution, or cell membrane perforation[28,32], all of which reliably 
contracted VSMCs. As arterial ICs express both myosin and actin, it was initially unclear why they were 
noncontractile. Recent findings that the contraction-regulating proteins MLCK[29] and calponin[30] are 
down-regulated in arterial ICs at least partially explain this phenomenon. Myosin seems absent, for 
example, from rabbit urethral[23] or rat mesenteric ICs[50], and human aortic ICs did not express smooth 
muscle α-actin, but a portion of them expressed neurokinin 1 receptor strongly[31], all of which suggests 
heterogeneity of ICs. 
INTRACELLULAR CALCIUM 
Information about changes in intracellular calcium comes from studies in ICs of rabbit portal 
vein[32,33,35] and guinea pig small mesenteric arteries[28].  
The most obvious feature of localised intracellular calcium release is that, unlike in VSMCs, it is not 
restricted to subplasmalemmal regions[28,32], but can take place in the central cytoplasm or even 
filopodia. In filopodia, the transient localised increases in intracellular calcium concentration ([Ca
2+
]i), 
sometimes referred to as “Ca2+ sparks”, are asynchronous. This implies that they are locally 
controlled[32] and that there are calcium stores either within them or close to their roots (which is why 
ultrastructural studies of filopodia would be required). 
Arterial ICs do not seem to be very active in terms of intracellular calcium release or changes in 
[Ca
2+
]i, as spontaneous calcium release events were produced in just over a quarter of them. The Ca
2+
 
sparks were mostly central and frequently resulted in the development of longer increases in [Ca
2+
]i, 
termed “calcium transients”. Calcium transients varied in spatial spread, sometimes including a major 
portion and sometimes the whole of the cell volume, but none of them resulted in IC contraction and, if 
they were repetitive, they were irregular in rhythm[28]. Conversely, Ca
2+
 sparks in VSMCs under these 
conditions remain localised and seldom develop into calcium transients[106,107]. This difference in 
spread might reflect the differences in spatial arrangement of intracellular calcium release microdomains 
between ICs and VSMCs and/or differences in their number or sensitivity. Changes in amplitude and 
duration of Ca
2+
 signals were shown to control the activity of several transcriptional regulators 
differentially[108]. The spatiotemporal pattern of calcium signalling in arterial ICs is altered from brief 
and peripheral toward longer-lasting release events taking place closer to the nucleus. It is therefore 
possible that calcium release events in these cells not only regulate the activity of membrane proteins, but, 
in the longer term, also regulate/modulate gene expression. 
Rabbit portal vein ICs displayed spontaneous rhythmical [Ca
2+
]i oscillations at room 
temperature[32,33,35], which suggested their potential role of pacemakers. These repetitive calcium 
transients often developed from an initial localised [Ca
2+
]i increase similar to a Ca
2+
 spark[35], which 
originated from a discrete central region of the cytoplasm corresponding to a perinuclear sarcoplasmic 
reticulum rich in ryanodine receptors (RyRs)[33]. This is different from VSMCs, where Ca
2+
 sparks 
originate from the subplasmalemmal sarcoplasmic reticulum[106,107]. 
The frequency of [Ca
2+
]i oscillations in portal vein ICs was similar to their frequency of spontaneous 
membrane depolarisations and it was shown that the two coincided[33,35]. Investigation of the 
mechanism of [Ca
2+
]i oscillations has shown that they resulted from Ca
2+
 release from the sarcoplasmic 
reticulum through IP3 receptors (IP3Rs) and RyRs, and that they depended on refilling of calcium stores 
through TRP nonselective cation channels, but not L-type Ca
2+
 channels[33]. The dependence of calcium 
release in ICs on both IP3Rs and RyRs is reminiscent of VSMCs. There the initial Ca
2+
 discharge is 
thought to be initiated by a RyR cluster and the IP3Rs support the propagation of Ca
2+
 waves from one 
RyR domain to the other[109]. It is not known yet how the depolarisation occurs in portal vein ICs once 





 ions reach the cell membrane. One possible mechanism is known from urethral ICs, where Ca
2+
 ions 
activate calcium-dependent chloride channels resulting in Cl
–
 efflux and depolarisation[55,110]. 
The frequency of [Ca
2+
]i oscillations in rabbit portal vein ICs correlated with the rate of initial slow 
increase in [Ca
2+
]i at the beginning of the increase. It seems that this phase determines the frequency of 
discharge and reflects some as-yet-unknown pacemaking process within the ICs[33]. However, only 
~40% of portal vein ICs showed a clear slow increase phase, whereas in the other ~60% this phase was 
flat. The depletion of calcium stores did not seem to play a role in determining the frequency of [Ca
2+
]i 
oscillations, as store refilling was fast (there was no refractory period) and happened during the 
descending phase of Ca
2+
 wave[33].  
In order to function as a pacemaker, a cell must be capable of not only producing rhythmic 
depolarisations, but also spreading them to other cells. For rabbit portal vein ICs, this proof came in the 
work of Harhun et al.[35]. Even following tissue dispersion, the ICs are sometimes seen contacting other 
cells (ICs or VSMCs) with their filopodia, offering a unique opportunity to investigate the transmission of 
signals between ICs themselves or between ICs and VSMCs. Technically difficult experiments involving 
confocal imaging of intracellular Ca
2+
 and/or voltage-clamp of single cells have shown that the 
transmission of the calcium signal between two ICs was rapid (<200 msec), but the transmission between 
an IC and a VSMC was delayed by several seconds and did not involve spread of depolarisation through 
the filopodia. It was therefore hypothesised that a diffusible substance is released by ICs which, after 
reaching VSMCs, causes their depolarisation. While the identity of this substance is unknown for portal 
vein ICs, the work on urinary bladder ICs suggests prostaglandins as possible candidates[21].   
ION CHANNELS AND ELECTRICAL PROPERTIES 
Apart from the higher capacitance of arterial ICs[28] presumably reflecting their bigger surface area, 
there were no significant differences in passive electrical properties between ICs and VSMCs[28,32].  
The voltage-dependent membrane currents of ICs were similar to those of VSMCs[28,32]. Both cell 
types had a voltage-gated, nifedipine-sensitive, L-type Ca
2+
 current and an outward current consisting of 
several, presumably K
+
 current, components. In arterial ICs, there was little, if any, contribution of 
voltage-sensitive Cl
–
 channels to the outward current[28]. The only difference between portal vein ICs 
and VSMCs was noticed in their spontaneous electrical events: while VSMCs discharged infrequent, but 
rapid, action potentials, the ICs produced repetitive, but slower, depolarisations[32](see above, in 





 channels by Ca
2+
 sparks taking place in their vicinity, were seen in portal vein ICs. 
Arterial ICs, in contrast to VSMCs, produced no or very few STOCs[28] and this difference might reflect 
their different function. STOCs in VSMCs hyperpolarise the membrane and inhibit their contraction[111]. 
The role STOCs might play in noncontractile ICs is not clear as yet. It is possible that portal vein ICs, 
being able to generate rhythmic spontaneous depolarisations, need a powerful hyperpolarisation 
mechanism to modulate this activity, whereas arterial ICs, which do not seem to generate rhythmic 
depolarisations, have no need for such a mechanism.  
The coupling of calcium release events to membrane currents in arterial ICs was generally weak (Fig. 
3). Only occasionally long-lasting calcium release events coincided with slow outward currents, which 
was different to VSMCs, where brief and localised Ca
2+
 sparks gave rise to similarly brief STOCs[28].  
The membrane of portal vein ICs was labelled with anti-TRPC3,6,7 antibodies, suggesting the 
expression of at least one of these channel subunit types[33]. ICs did not have Na
+
 current[28,32], further 
adding to the immunocytochemical and RT-PCR findings that they do not belong to neuronal lineage. 
The similarity in ion channel inventory between ICs and VSMCs argues in favour of the hypothesis that 
ICs belong to the smooth muscle cell lineage.  




FIGURE 3. Loose/absent coupling of calcium release events and membrane currents in arterial ICs. (A) Transmitted light image of an arterial IC 
loaded with calcium-sensitive fluorescent indicator (green pseudocolour) and patched with a glass pipette. (B) Line scan image of normalised 
calcium fluorescence obtained by repeatedly scanning the orange line in panel A over 100 sec. X axis shows time, y axis shows the position on 
the scanned line. Fluorescence signal is colour-coded; pixels in yellow and red indicate elevated intracellular calcium concentration. (C) Voltage 
protocol imposed on the patched cell – its membrane was held at –60, –40, –20, and 0 mV, each step for 25 sec. (D) Membrane current of the 
patched cell, recorded simultaneously with calcium imaging. Small transient inward current can be seen at –60 mV and long-lasting transient 
outward current at 0 mV. Calcium release events in the cell did not elicit membrane current (red arrows).  
ROLE IN BLOOD VESSELS 
The experimental data provide a strong case for pacemaking being the principal role of portal vein ICs. 
The presence of specialised pacemaking cells is consistent with the spontaneous activity of this vein[112]. 
These ICs produce spontaneous, rhythmical increases in [Ca
2+
]i[32,35], which can be transmitted to other 
cells either through direct contacts (in the case of IC-to-IC communication) or in a paracrine fashion (in 
the case of IC-to-VSMC communication)[35]. Moreover, rabbit portal vein ICs express c-kit[32], which 
is another feature they share with ICCs of the gastrointestinal tract. Little is known about any other 
markers the portal vein ICs might express and so it can be only assumed, by analogy to ICCs and arterial 
ICs, that they too belong to the smooth muscle cell lineage. The questions whether ICs in veins perform 
other roles, e.g., mediation of neural signals to VSMCs, or whether ICs from mammalian veins other than 
portal also act as pacemakers, await further experimentation. There are indications that pacemaking by 
ICs could be a widespread phenomenon. Data obtained on ICs of the urogenital tract[23,42,52] and on 
ICCs of the gastrointestinal tract[63], suggest that low-pressure tube systems, in general, need pacemakers 
to drive the vasomotion or peristalsis and help propel the tube contents (blood, urine, semen, chyme, and 
perhaps lymph) forward.  
The above hypothesis is consistent with the observation that arterial ICs do not appear to act as 
pacemakers. In a high-pressure tube system, the forward movement of blood relies on the high-pressure 
gradient produced by the pumping action of the heart, so there is normally no need for spontaneous 
vasomotion and pacemakers. However, contraction waves coinciding with intercellular Ca
2+
 waves, 
suggestive of vasomotion, were elicited by adrenoceptor stimulation in rat mesenteric artery strips[113]. It 
would be interesting to find out whether prolonged exposure of single arterial ICs to an adrenoceptor 
agonist results in rhythmic [Ca
2+
]i oscillations.  
Arterial ICs are found throughout the tunica media and transmission electron micrographs do not 
provide evidence of their proximity to nerve fibres[28,29,30]. For these reasons, their role as 
intermediaries between nerves and VSMCs does not seem likely. 
Judging from their marker expression pattern, the arterial ICs belong to the smooth muscle cell 
lineage[29,30]. They express a majority of smooth muscle cell markers, but fall short of significantly 
expressing the proteins specific for the mature/contractile/differentiated phenotype: smoothelin, 
MLCK[29], calponin[30], and the SM2 isoform of SM-MHC[114]. This suggests that they are 
immature/phenotypically modulated/undifferentiated VSMCs. Although there is not enough evidence to 
call them “synthetic” VSMCs (as there is at present no proof that they migrate, synthesise ECM proteins, 
proliferate, and differentiate into contractile VSMCs), their functional properties (noncontractility, ability 
to change shape) indicate they might be just that. Constitutive presence of such cells in the vascular wall 
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would be important for the maintenance of its integrity. VSMCs of synthetic phenotype can be regarded 
as oligopotent progenitor cells playing a central role in vascular repair, as they can migrate to the site of 
injury, synthesise ECM components, proliferate, and differentiate into the contractile phenotype to 
replace damaged cells[115]. This normally beneficial capacity can be harmful under some circumstances, 
as VSMCs of the synthetic phenotype have also been implicated in a number of pathological conditions 
stemming from disorders in vascular remodelling (e.g., atherosclerosis[116,117]; restenosis after 
angioplasty[115,118]).  
Ideas that ICs might act as mechanoreceptors, sensing distension of the tissue they are in, or that they 
possess trophic or metabolic functions have been proposed on several occasions[28,53,119,120] (also in 
rat mesentery ICs[50]), but to date there is no experimental evidence to support them.  
Thus, a picture emerges where vascular ICs are a part of the spectrum of smooth muscle cell 
phenotypes[53,121] ranging from ICCs specialised for pacemaking at one end to the mature smooth 
muscle cells specialised for contraction at the other (Fig. 4).  
 
FIGURE 4. Diagram showing the possible spectrum of smooth muscle cell phenotypes and their features. 
FUTURE DIRECTIONS 
Implication of vascular ICs in vasomotion and possible implication in vascular proliferative diseases, such 
as atherosclerosis, postangioplasty restenosis, or vein bypass graft failure[81], could make them a 
promising, albeit sparse, target for therapeutic interventions. The ability to modulate selectively the 
function of distinct VSMC subpopulations (ICs being one of them) could lead to new, advanced 
therapeutic approaches for a range of cardiovascular pathologies, which rank among the leading causes of 
morbidity and mortality globally. A detailed understanding of the function of VSMC subpopulations will 
be essential for their selective pharmacological targeting.  
There have been only a handful of functional investigations of vascular ICs. Very little is known 
about ICs in some vascular beds, as the studies were carried out on a tissue level and only described the 
morphology of ICs. Future studies will have to address several important functional and structural aspects 
of vascular ICs. 
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The most pressing issue at the moment is the unavailability of a selective marker for arterial ICs. 
Such a marker would allow immunolabelling and visualisation of ICs in intact vessels, giving information 
about their number, localisation patterns, and possible connection into networks. A surface marker would 
boost investigations of single live arterial ICs by allowing their separation from the bulk of VSMCs in 
cell suspensions. The search for such a molecule using an immunocytochemical technique is slow and 
expensive, which is why high throughput (proteomic or molecular biological) approaches will be 
necessary. Such investigations would ideally result in a precise definition of various IC and smooth 
muscle cell subpopulations based on their protein inventories, which would clarify their position in the 
mesenchymal cell spectrum.  
Functional experiments investigating whether arterial ICs are able to migrate, proliferate, and 
differentiate into mature VSMCs would be the most straightforward way to clarify whether they are 
indeed the VSMCs of synthetic phenotype. The different patterns of intracellular Ca
2+
 release in ICs 
compared to VSMCs suggest regulation of different physiological processes. Better understanding of 
intracellular Ca
2+
 signalling in arterial ICs will improve understanding of their function and may help to 
elucidate their role. 
The portal vein is not a typical blood vessel. Its cellular arrangement with the outer longitudinal and 
the inner circular layer of smooth muscle cells is reminiscent of the intestine. It will therefore be 
important to establish whether there are ICs in other veins and, if so, whether they too act as pacemakers. 
The results obtained in the human pulmonary vein[71] and frog postcaval vein[34] indicate that both 
possibilities may be the case. Moreover, to better understand the origin and function of venous ICs, it 
would be interesting to establish whether they possess functional and structural features similar to arterial 
ICs: elongation of filopodia, active change of shape, expression of smooth muscle markers, and stress 
fibre–based actin cytoskeleton. 
Lastly, the work indicating the presence of ICs in amphibian vein[34], suggests they are an 
evolutionarily old cell type. Extension of studies to amphibian arteries and to blood vessels of aquatic 
vertebrates would provide valuable data on the phylogenesis of ICs.  
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